Cannabinoid Derivatives Developer Scientus Pharma Lands $11.5 Million Investment from Aphria
Aphria Announces $11.5 Million Strategic Investment In Scientus Pharma Innovative extraction process opens door to future cannabinoid based medical products LEAMINGTON, ON, Aug. 15, 2017 /CNW/ – Aphria Inc....